MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..9 of 9 - per page
Order by
Cellophil(TM) Biomedical Polymer - New and superior biomedical polymers for a new standard in the medical device industry.
Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
Micro Fine, Dry Powder Pulmonary Drug Delivery Technology Suite
Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More
A NEW AEROSOL TREATMENT FOR ASTHMA USING A NON-STEROIDAL COMPLEX WHICH PREVENTS BRONCHIAL REMODELLING
Aerosolized pharmaceutical composition with low potential toxicity, significantly reducing airway inflammation and remodelling More
Protein (Biomolecule) Transduction Domain (PTD)
Rheumatoid arthritis More
Substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] Thiadiazines as Potent Inhibitors of PDE4A, PDE4B, and PDE4D
A series of substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] thiadiazines that act as inhibitors of PDE4 More
SNP-Disease Association via a Comprehensive DNA Resource
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases More
SH2 Domain Binding Inhibitors
Grb2 SH2 domain signaling antagonists with enhanced binding affinity. More
Species-Independent A3 Adenosine Receptor Agonists
A novel agonist that is selective for the mouse A3AR while retaining selectivity for the human receptor. More
Allergy and Immunopharmacology Laboratory
The laboratory is active in the field of allergy and immunopharmacology of inflammation More
Displaying 1..9 of 9 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us